Related Experiment Video
Updated: May 26, 2026

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
Published on: April 11, 2019
A rare occurrence of isolated neutropenia with valproic acid: a case report
Susmita Chakraborty1, Jayanta Chakraborty, Srikrishna Mandal
1IPGME&R, Kolkata 700020.
Abstract:
Valproic acid, a conventional antiepileptic drug, is also used in the treatment of bipolar disorder, to provide rapid stabilization of the patient. Although thrombocytopenia is a potential threat, occurrence of suppression of the other cell lines in the bone marrow is also found rarely. Here in this study we report a case of a 28 year old female treated with valproic acid and risperidone for bipolar disorder, who developed isolated neutropenia within 6 months of commencement of therapy that got reversed soon after termination of valproic acid therapy. This finding lays further emphasis on regular monitoring of all cell lines in blood for better management and to prevent any serious bone marrow toxicity in the patients.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pharmaceutical Poisoning: Treatment Strategies
Drug Toxicity: Overview

